Pathology Driven Treatment: MSI, KRAS and Moving Forward

Dr. Kressin discusses GI molecular pathology and testing. This presentation includes sporadic verses inherited colon rectal cancer syndromes (Lynch syndrome and MMR testing), additional mutational testing (MMR, EGFR, NRAS/KRAS and BRAF) and when to perform mutational testing in colon rectal cancer. The algorithm for testing all new colon cancer is included in her discussion.